Company: BIAF
Filing Date: 2025-07-23
Form Type: 8-K
Source: 0001641172-25-020705
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-07-23
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01. Other Events.

On
July 23, 2025, bioAffinity Technologies, Inc., a Delaware corporation, (the “ Company”) issued a press release announcing
the release of a new case study in which CyPath® Lung identified a Stage 1A neuroendocrine tumor in the lung after PET scan, bronchoscopies
and a serum tumor marker test suggested it was non-cancerous inflammation.

A
copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.